Mechanisms of action of systemic antibiotics used in periodontal treatment and mechanisms of bacterial resistance to these drugs

Journal of Applied Oral Science

Volumn 20, Issue 3, 2012, Pages 295-305

  Soares, Geisla Mary Silva ^a   Figueiredo, Luciene Cristina ^a   Faveri, Marcelo ^a   Cortelli, Sheila Cavalca ^b   Duarte, Poliana Mendes ^a   Feres, Magda ^a  

^a GUARULHOS UNIVERSITY   (Brazil)

^b UNIVERSITY OF TAUBATÉ   (Brazil)

Author keywords

Antibiotics; Dru resistance; Infectiou diseases; Periodonta diseases

Indexed keywords

ANTIINFECTIVE AGENT; MACROLIDE; METRONIDAZOLE;

ANTIBIOTIC RESISTANCE; BACTERIUM; CELL MEMBRANE PERMEABILITY; DRUG EFFECT; HUMAN; METABOLISM; PENICILLIN RESISTANCE; PERIODONTAL DISEASE; PHYSIOLOGY; REVIEW;

ANTI-BACTERIAL AGENTS; BACTERIA; CELL MEMBRANE PERMEABILITY; DRUG RESISTANCE, BACTERIAL; HUMANS; MACROLIDES; METRONIDAZOLE; PENICILLIN RESISTANCE; PERIODONTAL DISEASES; TETRACYCLINE RESISTANCE;

EID: 84864685407     PISSN: 16787757     EISSN: 16787765     Source Type: Journal    
DOI: 10.1590/S1678-77572012000300002     Document Type: Review

References (172)

1. Abraham LJ, Berryman DI, Rood JI. Hybridization analysis of the class P tetracycline resistance determinant from the Clostridium perfrigens R-plasmid, pCW3. Plasmid. 1988;19:113-20.
2. Abu-Fanas SH, Drucker DB, Hull PS. Amoxicillin with clavulanic acid and tetracycline in periodontal therapy. J Dent. 1991;19:97-9.
3. Abu-Fanas SH, Drucker DB, Hull PS, Reeder JC, Ganguli LA. Identification and susceptibility to seven antimicrobial agents, of 61 gram-negative anaerobic rods from periodontal pockets. J Dent. 1991;19:46-50.
4. Andrés MT, Chung WO, Roberts MC, Fierro JF. Antimicrobial susceptibilities of Porphyromonas gingivalis, Prevotella intermedia, and Prevotella nigrescens spp. isolated in Spain. Antimicrob Agents Chemother. 1998;42:3022-3.
5. Ardila CM, Granada MI, Guzmán IC. Antibiotic resistance of subgingival species in chronic periodontitis patients. J Periodont Res. 2010;45:557-63.
6. Armitage GC. Comparison of the microbiological features of chronic and aggressive periodontitis. Periodontol 2000. 2010;53:70-88.
7. Arpin C, Canron MH, Noury P, Quentin C. Emergence of mefA and mefE genes in β-haemolytic streptococci and pneumococci in France. J Antimicrob Chemother. 1999;44:133-4.
8. Barza M, Brown RB, Shanks C, Gamble C, Weinstein L. Relation between lipophilicity and pharmacological behavior of minocycline, doxycycline, tetracycline and oxytetracycline in dogs. Antimicrob Agents Chemother. 1975;8:713-20.
9. Bernardo WL, Boriollo MFG, Gonçalves RB, Höfling JF. Staphylococcus aureus ampicillin-resistant from the odontological clinic environment. Rev Inst Med Trop Sao Paulo. 2005;47:19-24.
10. Bhatia N, Palta S, Arora K. Comparison of the effect of a single dose of erythromycin with pantoprazole on gastric content volume and acidity in elective general surgery patients. J Anaesthesiol Clin Pharmacol. 2011;27:195-8.
11. Bismuth R, Zilhao R, Sakamoto H, Guesdon JL, Courvalin P. Gene heterogeneity for tetracycline resistance in Staphylococcus spp. Antimicrob Agents Chemother. 1990;34:1611-4.
12. Blandizzi C, Malizia T, Lupetti A, Pesce D, Gabriele M, Giuca MR, et al. Periodontal tissue disposition of azithromycin in patients affected by chronic inflammatory periodontal diseases. J Periodontol. 1999;70:960-6.
13. Burdett V. Purification and characterization of Tet(M), a protein that renders ribosomes resistant to tetracycline. J Biol Chem. 1991;266:2872-7.
14. Burdett V. Streptococcal tetracycline resistance mediated at the level of protein synthesis. J Bacteriol. 1986;165:564-9.
15. Butaye P, Cloeckaert A, Schwarz S. Mobile genes coding for efflux-mediated antimicrobial resistance in Gram-positive and Gram-negative bacteria. Int J Antimicrob Agents. 2003;22:205-10.
16. Carvalho LH, D'Avila GB, Leão A, Goncalves C, Haffajee AD, Socransky SS, et al. Scaling and root planing, systemic metronidazole and professional plaque removal in the treatment of chronic periodontitis in a Brazilian population. II. microbiological results. J Clin Periodontol. 2005;32:406-11.
17. Carvallho LH, D'Avila GB, Leão A, Haffajee AD, Socransky SS, Feres M. Scaling and root planing, systemic metronidazole and professional plaque removal in the treatment of chronic periodontitis in a Brazilian population. I. clinical results. J Clin Periodontol. 2004;31:1017-76.
18. Chambers HF, Sande MA. Antimicrobial agents. General considerations. In: Gilman AG, Rall TW, Nies AS, Taylor P. The pharmacological basis of therapeutics. New York: Pergamon Press; 1996. p. 1026-9.
19. Chan Y, Chan CH. Antibiotic resistance of pathogenic bacteria from odontogenic infections in Taiwan. J Microbiol Immunol Infect. 2003;36:105-10.
20. Charpentier E, Gerbaud G, Courvalin P. Characterization of a new class of tetracycline-resistance gene tet(S) in Listeria monocytogenes BM4210. Gene. 1993;131:27-34.
21. Ciancio SG, Slots J, Reynolds HS, Zambon JJ, McKenna JD. The effect of short-term administration of minocycline HCI on gingival inflammation and subgingival microflora. J Periodontol. 1982;53:557-61.
22. Cionca N, Giannopoulou C, Ugolotti G, Mombeli A. Amoxicilin and metronidazole as an adjunct to full-mouth scaling and root planning of chronic periodontitis. J Periodontol. 2009;80:364-71.
23. Cionca N, Giannopoulou C, Ugolotti G, Mombelli, A. Microbiologic testing and outcomes of full-mouth scaling and root planing with or without amoxicillin/metronidazole in chronic periodontitis. J Periodontol. 2010;81:15-23.
24. Cohen SP, McMurry LM, Hooper DC, Wolfson JS, Levy SB. Cross-resistance to fluoroquinolones in multiple-antibioticresistant (Mar) Escherichia coli selected by tetracycline or choloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction. Antimicrob Agents Chemother. 1989;33:1318-25.
25. Cohen SP, McMurry LM, Levy SB. marA locus causes decreases expression of OmpF porin in multiple-antibiotic-resistant (Mar) mutants of Escherichia coli. J Bacteriol. 1988;170:5416-22.
26. Collins JG, Offenbacher S, Arnold RR. Effects of a combination therapy to eliminate Porphyromonas gingivalis in refractory periodontitis. J Periodontol. 1993;64:998-1007.
27. Connel SR, Tracz DM, Nierhaus KH, Taylor DE. Ribosomal protection proteins and their mechanism of tetracycline resistance. Antimicrob Agents Chemother. 2003;47:3675-81.
28. Davies J. Inactivation of antibiotics and the dissemination of resistance genes. Science. 1994;264:375-82.
29. Day LE. Tetracycline inhibition of cell-free protein synthesis. II. Effect of the binding of tetracycline to the components of the system. J Bacteriol. 1966;92 197-203.
30. Deas ED, Mealey LB. Response of chronic and aggressive periodontitis to treatment. Periodontol 2000. 2010;53:154-66.
31. De Barbeyrac B, Dutilh B, Quentin C, Renaudin H, Bébéar C. Susceptibility of Bacteroides ureolyticus to antimicrobial agents and identification of a tetracycline resistance determinant related to tetM. J Antimicrob Chemother. 1991;27:721-31.
32. De Rossi E, Blokpoel MC, Cantoni R, Branzoni M, Riccardi G, Young DB, et al. Molecular cloning and functional analysis of a novel tetracycline resistance determinant, tet(V), from Mycobacterium smegmatis. Antimicrob Agents Chemother. 1998;42:1931-7.
33. Doyle D, McDowall KJ, Butler MJ, Hunter IS. Characterization of an oxytetracycline-resistance gene, otrA, of Streptomyces rimosus. Mol Microbiol. 1991;5:2923-33.
34. Dublanchet A, Caillon J, Emond JP, Chardon H, Drugeon HD. Isolation of Bacteroides strains with reduced sensitivity to 5-nitroimidazoles. Eur J Clin Microbiol. 1986;5:346-7.
35. Falagas ME, Gorbach SL. Clindamycin and metronidazole. Med Clin North Am. 1995;79:845-67.
36. Feres M, Haffajee AD, Allard K, Som S, Goodson S, Socransky SS. Antibiotic resistance of subgingival species during and after antibiotic therapy. J Clin Periodontol. 2002;29:724-35.
37. Fiehn NE, Westergaard J. Doxycycline resistant bacteria in periodontally diseased individuals after systemic doxycycline therapy and in healthy individuals. Oral Microbiol Immunol. 1990;5:219-22.
38. Freeman CD, Klutman NE, Lamp KC. Metronidazole. A therapeutic review and update. Drugs. 1997;54:679-708.
39. Goh KL, Parasakthi N, Chuah SY, Toetsch M. Combination amoxicillin and metronidazole with famotidine in the eradication of Helicobacter pylori-a randomized, double-blind comparison of a three times daily and twice daily regimen. Eur J Gastroenterol Hepatol. 1997;9:1091-5.
40. Golub LM, Lee HM, Greenwald RA, Ryan ME, Sorsa T, Salo T, et al. A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis. Inflamm Res. 1997;46:310-9.
41. Goodson JM. Antimicrobial strategies for treatment of periodontal diseases. Periodontol 2000. 1994;5:142-68.
42. Goodson JM, Tanner A. Antibiotic resistance of the subgingival microbiota following local tetracycline therapy. Oral Microbiol Immunol. 1992;7:113-7.
43. Goodwin CS, Marshall BJ, Blincow ED, Wilson DH, Blackbourn S, Phillips M. Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies. J Clin Pathol. 1988;41:207-10.
44. Graham DY, Hoffman J, el-Zimaity HM, Graham DP, Osato M. Twice a day quadruple therapy (bismuth subsalicylate, tetracycline, metronidazole plus lansoprazole) for treatment of Helicobacter pylori infection. Aliment Pharmacol Ther. 1997;11:935-8.
45. Guerrero A, Griffiths GS, Nibali L, Suvan J, Moles DR, Laurell L, et al. Adjuntive benefits of systemic amoxicillin and metronidazole in non-surgical treatment of generalized aggressive periodontitis: a randomized placebo-contolled clinical trial. J Clin Periodontol. 2005;32:1096-107.
46. Guiney DG, Bouic K. Detection of conjugal transfer systems in oral, black-pigmented Bacteroides spp. J Bacteriol. 1990;172:495-7.
47. Guiney DG Jr, Hasegawa P, Davis CE. Expression in Escherichia coli of cryptic tetracycline resistance genes from Bacteroides R plasmids. Plasmid. 1989;11:248-52.
48. Hackbarth CJ, Chambers HF. Methicillin-resistant staphylococci: genetics and mechanisms of resistance. Antimicrob Agents Chemother. 1989;33:991-4.
49. Haffajee AD, Dibart S, Kent RL Jr, Socransky SS. Clinical and microbiological changes associated with the use of 4 adjunctive systemically administered agents in the treatment of periodontal infections. J Clin Periodontol. 1995;22:618-27.
50. Haffajee AD, Dibart S, Kent RL Jr, Socransky SS. Factor associated with different responses to periodontal therapy. J Clin Periodontol. 1995;22:628-36.
51. Haffajee AD, Patel M, Socransky SS. Microbiological changes associated with four different periodontal therapies for the treatment of chronic periodontitis. Oral Microbiol Immunol. 2008;23:148-57.
52. Haffajee AD, Torresyap G, Socransky SS. Clinical changes following four different periodontal therapies for the treatment of chronic periodontitis: 1-year results. J Clin Periodontol. 2007;34:243-53.
53. Haggoud A, Reysset G, Azeddoug H, Sebald M. Nucleotide sequence analysis of two 5-nitromidazole resistance determinants from Bacteroides strains and of a new insertion sequence upstream of the two genes. Antimicrob Agents Chemother. 1994;38:1047-51.
54. Hakenbeck R, Coyette J. Resistant penicillin-binding proteins. Cell Mol Life Sci. 1998;54:332-40.
55. Handal T, Olsen I, Walker CB, Caugant DA. β-lactamase protection and antimicrobial susceptibility of subgingival bacteria from refractory periodontitis. Oral Microbiol Immunol. 2004;19:303-8.
56. Hansen LM, McMurry LM, Levy SB, Hirsh DC. A new tetracycline resistance determinant, Tet H, from Pasteurella multocida specifying active efflux of tetracycline. Antimicrob Agents Chemother. 1993;37:2699-705.
57. Herrera D, Alonso B, León R, Roldán S, Sanz M. Antimicrobial therapy in periodontitis: the use of systemic antimicrobials against the subgingival biofi{ligature}lm. J Clin Periodontol. 2008;35(Suppl. 8):45-66.
58. Hirschl AM, Hentschel E, Schütze K, Nemec H, Pötzi R, Gangl A, et al. The efficacy of antimicrobial treatment in Campylobacter pylori-associated gastrit and duodenal ulcer. Scand J Gastroenterol Suppl. 1988;142:76-81.
59. Hoepelman IM, Schneider MM. Azithromycin: the first of the tissue-selective azalides. Int J Antimicrob Agents. 1995;5(3):145-67.
60. Horn R, Lavallée J, Robson HG. Susceptibilities of members of the Bacteroides fragilis group to 11 antimicrobial agents. Antimicrob Agents Chemother. 1992;36;2051-3.
61. Hoshino T, Ikeda T, Tomizuka N, Furukawa K. Nucleotide sequence of the tetracycline resistance gene of pTHT15, a thermophilic Bacillus plasmid: comparison with staphylococcal TcR controls. Gene. 1985;37:131-8.
62. Ince D, Hooper DC. Quinolone resistance due to reduced target enzyme expression. J Bacteriol. 2003;185:6883-92.
63. Ingham HR, Eaton S, Venables CW, Adams PC. Bacteroides fragilis resistant to metronidazole after long-term therapy. Lancet. 1978;1:214.
64. Ioannidou S, Tassios PT, Kotsovili-Tseleni A. Foustoukou M, Legakis NJ, Vatopoulos A. Antibiotic resistance rates and macrolide resistance phenotypes of viridians group streptococci from the oropharynx of healthy Greek children. Int J Antimicrob Agents. 2001;17:195-201.
65. Joesoef MR, Schmid GP. Bacterial vaginosis: review of treatment options and potential clinical indications for therapy. Clin Infect Dis. 1995;20:S72-9.
66. Jorgensen JH, Doern GV, Maher LA, Howell AW, Redding JS. Antimicrobial resistance among respiratory isolates of Haemophilus influenza, Moraxella catarrhalis, and Streptococcus pneumonia in the United States. Antimicrob Agents Chemother. 1990;34:2075-80.
67. Kaatz GW. Bacterial efflux pump inhibition. Curr Opin Investig Drugs. 2005;6:191-8.
68. Kapusnik-Uner JE, Sande MA, Chambers HF. Antimicrobial agents: penicillins, cephalosporins, and other beta-lactam antibiotics. In: Gilman AG, Hardman JG, Limbird LE. The pharmacological basis of therapeutic. New York: Pergamon Press; 1996. p. 1123-53.
69. Kim SM, Kim HC, Lee SW. Characterization of antibiotic resistance determinants in oral biofilms. J Microb. 2011;49:594-602.
70. Kinder SA, Holt SC, Korman KS. Penicillin resistance in the subgingival microbiota associated with adult periodontitis. J Clin Microbiol. 1986;23:1127-33.
71. King A, Bathgate T, Phillips I. Erythromycin susceptibility of viridans streptococci from the normal throat flora of patients treated with azithromycin or clarithromycin. Clin Microbiol Infect. 2002;8:85-92.
72. Kornman KS, Karl EH. The effect of long-term low-dose tetracycline therapy on the subgingival microflora in refractory adult periodontitis. J Periodontol. 1982;53:604-10.
73. Laatsch LJ. Hohenfeldt PR, Kos WL. Antibiotic susceptibility of black-pigmented Bacteroides isolates from the human oral cavity. Antimicrob Agents Chemother. 1982;22:698-700.
74. Lacroix JM, Walker CB. Detection and incidence of the tetracycline resistance determinant tet(M) in the microflora associated with adult periodontitis. J Periodontol. 1995;66:102-8.
75. Lacroix JM, Walker CB. Detection and prevalence of the tetracycline resistance determinant Tet Q in the microbiota associated with adult periodontitis. Oral Microbiol Immunol. 1996;11:282-8.
76. Larsen T. Susceptibility of Porphyromonas gingivalis in biofilms to amoxicillin, doxycycline and metronidazole. Oral Microbiol Immunol. 2002;17:267-71.
77. Larsen T, Fiehn NE. Development of resistance to metronidazole and minocycline in vitro. J Clin Periodontol. 1997; 24: 254-259.
78. LeBlanc DJ, Lee LN, Titmas BM, Smith CJ, Tenover FC. Nucleotide sequence analysis of tetracycline resistance gene tetO from Streptococcus mutans DL5. J Bacteriol. 1988;170:3618-26.
79. Leclercq R. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin Infect Dis. 2002;34:482-92.
80. Levy SB. Evolution and spread of tetracycline resistance determinants. J Antimicrob Chemother. 1989;24:1-3.
81. Li XZ, Nikaido H. Efflux-mediated drug resistance in bacteria. Drugs. 2004;64:159-204.
82. Listgarten MA, Lai CH, Young V. Microbial composition and pattern of antibiotic resistance in subgingival microbial samples from patients with refractory periodontitis. J Periodontol. 1993;64:155-61.
83. Loberto JCS, Martins CAP, Santos SSF, Cortelli JR, Jorge AOC. Staphylococcus spp. in the oral cavity and periodontal pockets of chronic periodontitis patients. Braz J Microb. 2004;35:64-8.
84. Loesche WJ, Syed SA, Laughon BE, Stoll J. The bacteriology of acute necrotizing ulcerative gingivitis. J Periodontol. 1982;53:223-30.
85. Lugo-Miro VI, Green M, Mazur L. Comparison of different metronidazole therapeutic regiments for bacterial vaginosis. A meta-analysis. JAMA. 1992;268:92-5.
86. Maestre JR, Bascones A, Sánchez P, Matesanz P, Aguilar L, Giménez MJ, et al. Odontogenic bacteria in periodontal disease and resistance patterns to common antibiotics used as treatment and prophylaxis in odontology in Spain. Rev Esp Quimioter. 2007;20:61-7.
87. Magnusson I, Low SB, McArthur WP, Marks RG, Walker CB, Maruniak J, et al. Treatment of subjects with refractory periodontal disease. J Clin Periodontol. 1994;21:628-37.
88. Magnusson I, Marks RG, Clark WB, Walker CB, Low SB, McArthur WP. Clinical, microbiological and immunological characteristics of subjects with "refractory" periodontal disease. J Clin Periodontol. 1991;18:291-9.
89. Mandell GL, Phillips RW. Antimicrobial agents: penicillins, cephalosporins, and other beta-lactam antibiotics. In: Gilman AG, Hardman JG, Limbird LE. The pharmacological basis of therapeutic. New York: Pergamon Press; 1996. p. 1073-101.
90. Maxwell IH. Studies of the binding of thetracycline to ribosomes in vitro. Mol Pharmacol. 1968;4:25-37.
91. McMurry L, Petrucci RE Jr, Levy SB. Active efflux of tetracycline encoded by four genetically different tetracycline resistance determinants in Escherichia coli. Proc Natl Acad Sci USA. 1980;77:3974-7.
92. McMurry LM, Park BH, Burdett V, Levy SB. Energy-dependent efflux mediated by class L (tetL) tetracycline resistance determinant from streptococci. Antimicrob Agents Chemother. 1987;31:1648-50.
93. Mégraud F. Antibiotic resistance in Helicobacter pylori infection. Br Med Bull. 1998;54:207-16.
94. Mestnik MJ, Feres M, Figueiredo LC, Duarte PM, Lira EAG, Faveri M. Short-term benefits of the adjunctive use of metronidazole plus amoxicillin in the microbial profile and in the clinical parameters of subjects with generalized aggressive periodontitis. J Clin Periodontol. 2010;37:353-65.
95. Moore RA, Beckthold B, Bryan LE. Metronidazole uptake in Helicobacter pylori. Can J Microbiol. 1995;41:746-9.
96. Müller HP, Holderrieth S, Burkhardt U, Höffler U. In vitro antimicrobial susceptibility of oral strains of Actinobacillus actinomycetencomitans to seven antibiotics. J Clin Periodontol. 2002;29:736-42.
97. Müller M. Mode of action of metronidazole on anaerobic bacteria and protozoa. Surgery. 1983;93:165-71.
98. Nakae T. Outer-membrane permeability of bacteria. Crit Rev Microbiol. 1986;13:1-62.
99. Nesin M, Svec P, Lupski JR, Godson GN, Kreiswirth B, Kornblum J, et al. Cloning and nucleotide sequence of a chromosomally encoded tetracycline resistance determinant, tetA(M), from a pathogenic, methicillin-resistance strain of Staphylococcus aureus. Antimicrob Agents Chemother. 1990;34:2273-6.
100. Nikaido H. Multidrug resistance in bacteria. Annu Rev Biochem. 2009;78:119-46.
101. Nikaido H. Prevention of drug access to bacterial targets: permeabitity barriers and active aafflux. Science. 1994;264:382-8.
102. Nikolich MP, Shoemaker NB, Salyers AA. A Bacteroides tetracycline resistance gene represents a new class of ribosome protection tetracycline resistance. Antimicrob Agents Chemother. 1992;36:1005-12.
103. Nyfors S, Könönen E, Syrjänen R, Komulainen E, Jousimies-Somer H. Emergence of penicillin resistance among Fusobacterium nucleatum populations of commensal oral flora during early childhood. J Antimicrob Chemother. 2003;51:107-12.
104. Olsvik B, Flynn MJ, Tenover FC, Slots J, Olsen I. Tetracycline resistance in Prevotella isolates from periodontally diseased patients in due to the tet(Q) gene. Oral Microbiol Immunol. 1996;11:304-8.
105. Olsvik B, Hansen BF, Tenover FC, Olsen I. Tetracyclineresistant micro-organisms recovered from patients with refractory periodontal disease. J Clin Periodontol. 1995;22:391-6.
106. Osvik B, Olsen I, Tenover FC. Detection of tet(M) and tet(O) using the polymerase chain reaction in bacteria isolated from patients with periodontal disease. Oral Microbiol Immunol. 1995;10:87-92.
107. Olsvik B, Olsen I, Tenover FC. The tet(Q) gene in bacteria isolated from patients with refractory periodontal disease. Oral Microbiol Immunol. 1994;9:251-5.
108. Olsvik B, Tenover FC, Olsen I, Rasheed JK. Three subtypes of tet(M) gene identified in bacterial isolates from periodontal pockets. Oral Microbiol Immunol. 1996;11:299-303.
109. Pato ML. Tetracycline inhibits propagation of deoxyribonucleic acid replication and alters membrane properties. Antimicrob Agents Chemother. 1977;11:318-323.
110. Poulsen SM, Kofoed C, Vester B. Inhibition of the ribosomal peptidyl transferase reaction by the mycarose moiety of the antibiotics carbomycin, spiramycin and tylosin. J Mol Biol. 2000;304:471-81.
111. Quon DV, d'Oliveira CE, Johnson PJ. Reduced transcription of the ferredoxin gene in metronidazole-resistant Trichomonas vaginalis. Proc Natl Acad Sci U.S.A. 1992;89:4402-6.
112. Rams TE, Dujardin S, Sautter JD, Degener JE, Van Winkelhoff AJ. Spiramycin resistance in human periodontitis microbiota. Anaerobe. 2011;17:201-5.
113. Ramos JL, Martínez-Bueno M, Molina-Henares AJ, Terán W, Watanabe K, Zhang X, et al. The TetR family of transcriptional repressors. Microbiol Mol Biol Ver. 2005;69:326-56.
114. Ready D, Bedi R, Spratt DA, Mullany P, Wilson M. Prevalence, proportions, and identities of antibiotic-resistant bacteria in the oral microflora of healthy children. Microb Drugs Resist. 2003;9:367-72.
115. Ready D, Roberts AP, Pratten J. Spratt DA, Wilson M, Mullany P. Composition and antibiotic resistance profile of microcosm dental plaques before and after exposure to tetracycline. J Antimicrob Chemother. 2002;49:769-75.
116. Reysset G. Genetics of 5-nitroimidazole resistance in Bacteroides species. Anaerobe. 1996;2:59-69.
117. Roberts MC. Antibiotic toxicity, interactions and resistance development. Periodontol 2000. 2002;28:280-97.
118. Roberts MC. Tetracycline resistance determinants: mechanisms of action, regulation of expression, genetic mobility, and distribution. FEMS Microbiol Rev. 1996;19:1-24.
119. Roberts MC, Hillier SL. Genetic basis of tetracycline resistance in urogenital bacteria. Antimicrob Agents Chemother. 1990;34:261-4.
120. Roberts MC, Lansciardi J. Transferable Tet M in Fusobacterium nucleatum. Antimicrob Agents Chemother. 1990;34:1836-8.
121. Roberts MC, Moncla BJ. Tetracycline resistance and TetM in oral anaerobic bacteria and Neisseria perflava-N. sicca. Antimicrob Agents Chemother. 1988;32:1271-3.
122. Roberts MC, Pang YJ, Spencer RC, Winstanley TG, Brown BA, Wallace RJ Jr. Tetracycline resistance in Moraxella (Branhamella) catarrhalis: demonstration of two clonal outbreaks by using pulsed-field gel electrophoresis. Antimicrob Agents Chemother. 1991;35:2453-5.
123. Roberts MC, Sutcliffe J, Courvalin P, Jensen LB, Rood J, Seppala H. Nomenclature for macrolide and macrolidelincosamide-streptogramin B resistance determinants. Antimicrob Agents Chemother. 1999;43:2823-30.
124. Robicsek A, Strahilevitz J, Jacoby GA, Macielag M, Abbanat D, Park CH, et al. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat Med. 2006;12:83-8.
125. Rodrigues RM, Gonçalves C, Souto R, Feres-Filho EJ, Uzeda M, Colombo AP. Antibiotic resistance profile of the subgingival microbiota following systemic or local tetracycline therapy. J Clin Periodontol. 2004;31:420-7.
126. Salyers AA, Speer BS, Shoemaker NB. New perspectives in tetracycline resistance. Mol Microbiol. 1990;4:151-6.
127. Sanai Y, Persson GR, Starr JR, Luis HS, Bernardo M, Leitao J, et al. Presence and antibiotic resistance of Porphyromonas gingivalis, Prevotella intermedia, and Prevotella nigrescens in children. J Clin Periodontol. 2002;29:929-34.
128. Sanders CC, Sanders WE Jr, Goering RV, Werner V. Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes. Antimicrob Agents Chemother. 1984;26:797-801.
129. Scher KS. Emergence of antibiotic resistant strains of Bacteroides fragilis. Surg Gynecol Obstet. 1988;167:175-9.
130. Schnappinger D, Hillen W. Tetracyclines: antibiotic action, uptake, and resistance mechanisms. Arch Microbiol. 1996;165:359-69.
131. Sedgley CM, Lennan SL, Clewell DB. Prevalence, phenotype and genotype of oral enterococci. Oral Microbiol Immunol. 2004;19:95-101.
132. Sedlacek MJ, Walker C. Antibiotic resistance in an in vitro subgingival biofilm model. Oral Microbiol Immunol. 2007;22:333-9.
133. Sefton AM. Macrolides and changes in the oral flora. Inter J Antimicrob Agents. 1999;11:S23-9;S31-2.
134. Seymour RA, Hogg SD. Antibiotics and chemoprophylaxis. Periodontol 2000. 2008;46:80-108.
135. Sharma R, Sharma CL, Kapoor B. Antibacterial resistance: current problems and possible solutions. Indian J Med Sci. 2005;59:120-9.
136. Shinn D. Metronidazole in acute ulceration gingivitis. Lancet. 1962;1:1191.
137. Shoemaker NB, Barber RD, Salyers AA. Cloning and characterization of a Bacteroides conjugal tetracyclineerythromycin resistance element by using a shuttle cosmid vector. J Bacteriol. 1989;171:1294-302.
138. Silva MP, Feres M, Siroto TA, Soares GM, Mendes JAV, Faveri M, et al. Clinical and microbiological benefits of metronidazole alone or with amoxicillin as adjuncts in the treatment of chronic periodontitis: a randomized placebo-controlled clinical trial. J Clin Periodontol. 2011;38:828-37.
139. Socransky SS, Haffajee AD. Dental biofi{ligature}lms: diffi{ligature}cult therapeutic targets. Periodontol 2000. 2002;28:12-55.
140. Sóki J, Gal M, Brazier JS, Rotimi VO, Urbán E, Nagy E, et al. Molecular investigation of genetic elements contributing to metronidazole resistance in Bacteroides strain. J Antimicrob Chemother. 2006;57:212-20.
141. Soll AH. Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology. JAMA. 1996;275:622-9.
142. Speer BS, Shoemaker NB, Salyers AA. Bacterial resistance to tetracycline: mechanisms, transfer, and clinical significance. Clin Microbiol Rev. 1992;5:387-99.
143. Spratt BG. Biochemical and genetical approaches to the mechanism of action of penicillin. Philos Trans R Soc Lond B Biol Sci. 1980;289:273-83.
144. Spratt BG. The mechanism of action of penicillin. Sci Prog. 1978;65:101-28.
145. Spratt BG. Resistance to antibiotics mediated by target alterations. Science. 1994;264:388-93.
146. Stabholz A, Kettering J, Aprecio R, Zimmerman G, Baker PJ, Wikesjö UM. Antimicrobial properties of human dentin impregnated with tetracycline HCl or chlorhexidine. An in vitro study. J Clin Periodontal. 1993;20:557-62.
147. Stupnicki T, Taufer M, Denk H, Ratschek M, Spath P, Graf K. Triple therapy with sucralfate, amoxicillin and metronidazole for healing duodenal ulcer and eradicating Helicobacter pylori infection. Aliment Pharmacol Ther. 1996;10:193-7.
148. Suarez G, Nathans D. Inhibition of aminoacyl tRNA binding to ribosomes by tetracycline. Biochem Biophys Res Commun. 1965;18:743.
149. Sutter VL, Finegold SM. Susceptibility of anaerobic bacteria to 23 antimicrobial agents. Antimicrob Agents Chemother. 1976;10:736-52.
150. Sutter VL, Jones MJ, Ghoneim AT. Antimicrobial susceptibilities of bacteria associated with periodontal disease. Antimicrob Agents Chemother. 1983;23:483-6.
151. Sweeney LC, Dave J, Chambers PA, Heritage J. Antibiotic resistance in general dental practice-a cause for concern? J Antimicrobial Chemotherapy. 2004;53:567-76.
152. Tally FP, Snydman D, Shimmel M. Mechanisms of antimicrobial resistance of Bacteroides fragilis in Phillips I, Collier J (editors): Metronidazole: Proceedings of the Second International Symposium on Anaerobic Infections. London: Academic Press; 1979.
153. Tauch A, Pühler A, Kalinowski J, Thierbach G. TetZ, a new tetracycline resistance determinant discovered in gram-positive bacteria, shows high homology to gram-negative regulated efflux systems. Plasmid. 2000;44:285-91.
154. Trinh S, Haggoud A, Reysset G, Sebald M. Plasmids pIP419 and pIP421 from Bacteroides: 5-nitroimidazole resistance genes and their upstream insertion sequence elements. Microbiology. 1995;141:927-35.
155. Trinh S, Reysset G. Identification and DNA sequence of the mobilization region of the 5-nitroimidazole resistance plasmid pIP421 from Bacteroides fragilis. J Bacteriol. 1997;179:4071-4.
156. Vachon V, Lyew DJ, Coulton JW. Transmembrane permeability channels across the outer membrane of Haemophilus influenza type b. J Bacteriol. 1985;162:918-24.
157. Van Winkelhoff AJ, Herrera D, Oteo A, Sanz M. Antimicrobial profiles of periodontal pathogens isolated from periodontitis patients in The Netherlands and Spain. J Clin Periodontol. 2005;32:891-8.
158. Van Winkelhoff AJ, Herrera Gonzales D, Winkel EG, Dellemijn-Kippuw N, Vandenbroucke-Grauls CM, Sanz M. Antimicrobial resistance in the subgingival microflora in patients with adult periodontitis. A comparison between the Netherlands and Spain. J Clin Periodontol. 2000;27:79-86.
159. Van Winkelhoff AJ, Rodenburg JP, Goené RJ, Abbas F, Winkel EG, De Graaff J. Metronidazole plus amoxycillin in the treatment of Actinobacillus actinomycetemcomitans associated periodontitis. J Clin Periodontol. 1989;16:128-31.
160. Van Winkelhoff AJ, Tijhof CJ, De Graaff J. Microbiological and clinical results of metronidazole plus amoxicillin therapy in Actinobacillus actinomycetemcomitans associated periodontitis. J Periodontol. 1992;63:52-7.
161. Van Winkelhoff AJ, Winkel EG, Barendregt D, Dellemijn-Kippuw N, Stijne A, Van Der Velder. Beta-Lactamase producing bacteria in adult periodontitis. J Clin Periodontol. 1997;24:538-43.
162. Villideu A, Diaz-Torres ML, Hunt N, McNab R, Spratt DA, Mullany. Prevalence of tetracycline resistance genes in oral bacteria. Antimicrob Agents Chemother. 2003;47:878-82.
163. Walker CB. The acquisition of antimicrobial resistance in the periodontal microflora. Periodontol 2000. 1996;10:79-88.
164. Walker CB. Selected antimicrobial agents: mechanisms of action, side effects and drug interactions. Periodontol 2000. 1996;10:12-28.
165. Walker CB, Karpinia K, Baehni P. Chemotherapeutics: antibiotics and other antimicrobials. Periodontol 2000. 2004;36:146-65.
166. Walsh C. Where will new antibiotics come from? Nat Rev Microbiol. 2003;1:65-70.
167. Whittle G, Whitehead TR, Hamburger N, Shoemaker NB, Cotta MA, Salyers AA. Identification of a new ribosomal protective type of tetracycline resistance gene, tet(36), from swine manure pits. Appl Environ Microbiol. 2003;69:4151-8.
168. Williams BL, Osterberg SK, Jorgensen J. Subgingival microflora of periodontal patients on tetracycline therapy. J Clin Periodontol. 1979;6:210-21.
169. Yocum RR, Rasmussen JR, Strominger JL. The mechanism of action of penicillin. Penicillin acylates the active site of Bacillus stearothermophilus D-alanine carboxypeptidase. J Biol Chem. 1980;255:3977-86.
170. Yonath A. Ribosomal crystallography: peptide bond formation, chaperone assistance and antibiotics activity. Mol Cells. 2005;20:1-16.
171. Zihao R, Papadopoulou B, Courvalin P. Occurrence of the Campylobacter resistance gene tetO in Enterococcus and Streptococcus spp. Antimicrob Agents Chemother. 1988;32:1793-6.
172. Zuckerman JM, Qamar F, Bono BR. Review of macrolides (azithromycin, clarithromycin), ketolids (telithromycin) and glycylcyclines (tigecycline). Med Clin North Am. 2011;95;761-91.